Browsing by Contributors Fasching, Peter A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 5 of 5
PreviewIssue DateTitleContributor(s)
2016 IJE Volume 45 Issue 5 October (31).pdf.jpg2016Association of vitamin D levels and risk of ovarian cancer : a Mendelian randomization studyOng, Jue-sheng; Cuellar-partida, Gabriel; Lu, Yi; Ovarian, Australian; Study, Cancer; Fasching, Peter A; Hein, Alexander; Burghaus, Stefanie; Beckmann, Matthias W
JoCO 2018 Volume 36 Issue 22 August (4).pdf.jpg2018BRCA1 / 2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer : Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto StudyFasching, Peter A; Loibl, Sibylle; Hu, Chunling; Hart, Steven N; Shimelis, Hermela; Moore, Raymond; Tesch, Hans; Untch, Michael; Rezai, Mahdi; Gerber, Bernd; Costa, Serban Dan; Fehm, Tanja; Huober, Jens; Liedtke, Cornelia; Weinshilboum, Richard M; Wang, Liewei; Ingle, Ja
GYNONC 2017 Voluem 145 Issue 1 April (30).pdf.jpg2017Gynecologic Oncology Genetic risk factors for ovarian cancer and their role for endometriosis riskBurghaus, Stefanie; Fasching, Peter A; Häberle, Lothar; Rübner, Matthias; Büchner, Kathrin; Blum, Simon; Engel, Anne; Ekici, Arif B; Hartmann, Arndt; Hein, Alexander; Beckmann, Matthias W; Renner, Stefan P
JoCO 2018 Volume 36 Issue 24 August (22).pdf.jpg2018Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor – Positive , Human Epidermal Growth Factor Receptor 2 – Negative Advanced Breast Cancer :Slamon, Dennis J; Neven, Patrick; Chia, Stephen; Fasching, Peter A; Laurentiis, Michelino De; Im, Seock-ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J; Mart, Miguel; Nusch, Arnd; Sonke, Gabe S; De, Luis; Beck, J Thaddeus; Pivot, Xavier; Vidam, Gena; Wa
2018 JoCO Volume 36 Issue 13 May (2).pdf.jpg2018Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2 – Positive Breast Cancer in the GeparQuinto ( G5 ) Study ( GBG 44 )Untch, Michael; Minckwitz, Gunter Von; Gerber, Bernd; Schem, Christian; Rezai, Mahdi; Fasching, Peter A; Tesch, Hans; Eggemann, Holm; Hanusch, Claus; Huober, Jens; Solbach, Christine; Jackisch, Christian; Kunz, Georg; Blohmer, Jens-uwe; Hauschild, Maik; Fehm, Tanja; Nekl